All Stories

  1. Focus on pharma in acute coronary syndrome
  2. European Heart Journal – Cardiovascular Pharmacotherapy has received its first Impact Factor of 6.723
  3. Antiplatelet treatment in acute coronary syndrome. Still an issue
  4. Unsolved issues in oral anticoagulation treatment in atrial fibrillation
  5. European Heart Journal – Cardiovascular Pharmacotherapy: now accepted for an official Impact Factor
  6. EHJ Cardiovascular Pharmacotherapy has Impact Factor
  7. Adherence to guidelines, compliance to treatment, and treatment quality
  8. OUP accepted manuscript
  9. Impact of climate and air pollution on acute coronary syndromes: an update from the European Society of Cardiology Congress 2017
  10. Metabolic control, anticoagulation, and gender aspects
  11. Coronary artery disease and arrhythmias
  12. ESC working group position paper on myocardial infarction with non-obstructive coronary arteries